Clinical Trials Sponsored by Abby Siegel

Total 645 results

Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Plaque-Type Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Diaper Rash

United States, Dominican Republic, Ecuador, Panama
Urban Regeneration Institute
Szeged University

Completed

Effectiveness of Different Membrane Applications in Vertical Ridge Augmentation

Dental Implants | Bone Regeneration | Polytetrafluoroethylene

Hungary
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

Alopecia

Korea, Republic of, Taiwan, Singapore, Hong Kong, Chile
Pierre Singer

Completed

Effects of Oral Nutrition Supplement in Thai Malnourished Patients

Malnourished | Hospitalized

Israel
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis

Psoriasis

Russian Federation, Ireland, Germany, Netherlands, United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

Acne Vulgaris

United States
Stiefel, a GSK Company

Completed

A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects

Psoriasis

United States, Germany
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Acne Vulgaris | Acne

United States, Canada, Belize
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne

Acne

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

Acne Vulgaris

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

Skin Infections, Bacterial

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%

Dermatitis, Seborrheic
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies

Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne

Acne Vulgaris

Argentina
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies

Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Withdrawn

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Plaque Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Hand Dermatosis

United States
Stiefel, a GSK Company

Completed

Study on Anti-inflammatory Effects of Topical R115866 Gel

Cutaneous Inflammation

Belgium
Stiefel, a GSK Company

Completed

An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis

Psoriasis

Netherlands
Stiefel, a GSK Company

Completed

Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis

Ichthyosis, Lamellar

Netherlands, Sweden, Germany, Belgium, Canada, Dominican Republic, France, Italy, Norway
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

Dermatitis, Chronic

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects

Hyperhidrosis

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

Psoriasis

United States
Stiefel, a GSK Company

Completed

U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule

Onychomycosis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

Onychomycosis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne

Acne

United States
Stiefel, a GSK Company

Completed

8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.

Onychomycosis

United States, South Africa, Canada, Dominican Republic, Ecuador, Honduras, Panama
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301

Acne Vulgaris

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne

Acne Vulgaris

Spain
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Assess Blood Levels of Itraconazole During a Two-Week Period

Healthy

United States
Stiefel, a GSK Company

Completed

An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne

Acne

Belgium, Netherlands
Sibel ÖZTÜRK

Recruiting

The Effect of Pregnant Women's Maneuvers on Pregnancy Distress and Perception of Maternity Role"

Pregnancy Related | Mother-Child Relations

Turkey
Oncomfort
University of Liege

Completed

Healthy Volunteer Undergoing Painful Stimuli With and Without Hypnosis and Virtual Reality (SMARTHY)

Digital Sedation

Belgium
Sibel Naycı
Mersin University

Unknown

The Prevalence of Small Airways Dysfunction In COPD Patients and The Impact on COPD Control

COPD | Small Airway Disease

Turkey
University of Liege
Pfizer

Recruiting

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Coronavirus Disease 2019 (Covid19) | Hematopoietic Neoplasms

Belgium
Sibel Küçükoğlu

Completed

Facilitated Tucking Position and Reiki Efficacy in Orogastric Tube Insertion

Infant, Premature, Diseases | Feeding Behavior | Premature

Turkey
Sibel Naycı
Mersin University

Unknown

The Prevalence Of Small Airways Dysfunction In Asthma Patients And The Impact On The Asthma Control

Asthma | Small Airway Disease

Turkey
University of Liege
Solidaris

Completed

Health Literacy in the General Population in Belgium

Health Literacy

Belgium

3

Subscribe